Literature DB >> 3532021

Prenatal diagnosis of urinary tract abnormalities by ultrasound.

I Helin, P H Persson.   

Abstract

The capacity of a general ultrasound screening program to detect fetal malformations affecting the urinary tract was evaluated in an epidemiologic study. A total of 11,986 pregnant women, representing 97% of the pregnant population in Malmö, Sweden, from April 1978 through August 1983 were examined. On routine examinations performed by midwives in the 17th and 33rd gestational weeks, the fetal anatomy was carefully surveyed. The overall frequency of fetal malformations was 0.5%, with urinary tract abnormalities representing approximately 50% of the total number. In 20 of 33 cases, the ultrasound findings were those of hydronephrosis or hydroureter. In ten cases, a cystic renal malformation was found, and the remaining three cases represented double renal pelvis, Potter syndrome, and posterior urethral valve. A total of 28 abnormalities were unilateral and five bilateral. No case of unilateral absence of renal tissue was noted prenatally. Prenatal diagnosis of urinary tract abnormalities known to precipitate neonatal urosepsis and subsequent renal scarring and other complications makes it possible to start an early antibiotic prophylaxis regimen. A complete workup of the infants can be started early and before life-threatening complications occur.

Entities:  

Mesh:

Year:  1986        PMID: 3532021

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  25 in total

1.  Reliability of ultrasound in the prenatal diagnosis of urinary tract abnormalities.

Authors:  A J Barakat; M G Butler; C G Cobb; J W Coursey; D Shah
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

2.  Long term outcome of management of antenatally diagnosed pelvi-ureteric junction obstruction.

Authors:  Vishesh Jain; Sandeep Agarwala; Veereshwar Bhatnagar; Arun Kumar Gupta; Rakesh Kumar; Chander Sekhar Bal
Journal:  Indian J Pediatr       Date:  2011-08-10       Impact factor: 1.967

Review 3.  Congenital/inherited kidney diseases: how to identify them early and how to manage them.

Authors:  Jean-Pierre Grünfeld
Journal:  Clin Exp Nephrol       Date:  2005-09       Impact factor: 2.801

4.  Antenatal sonography revealed bilateral moderate hydronephrosis without dilatation of ureters or bladder in a fetus at 16 weeks' gestation. This was confirmed at 32 weeks. What advice should be given to the obstetrician regarding intra-uterine intervention, delivery, etc?

Authors:  D F Thomas
Journal:  Pediatr Nephrol       Date:  1991-05       Impact factor: 3.714

5.  Clinical spectrum of antenatally detected urinary tract abnormalities with respect to hydronephrosis at postnatal ultrasound scan.

Authors:  Ibrahim Gokce; Nese Biyikli; Halil Tugtepe; Tufan Tarcan; Harika Alpay
Journal:  Pediatr Surg Int       Date:  2012-03-18       Impact factor: 1.827

Review 6.  Antenatal diagnosis of urological disorders by ultrasound: a critical review.

Authors:  D De Wolf; F Keuppens; M Temmerman; M Verboven; M Deneyer; M Delree; L Sacre-Smits
Journal:  Eur J Pediatr       Date:  1989-10       Impact factor: 3.183

7.  Clinical relevance and implications of antenatal hydronephrosis.

Authors:  J A Dudley; J M Haworth; M E McGraw; J D Frank; E J Tizard
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-01       Impact factor: 5.747

Review 8.  Nonvascular needle and shunt placements for fetal therapy.

Authors:  W Holzgreve; M I Evans
Journal:  West J Med       Date:  1993-09

9.  The Frequencies of the Urinary Anomalies which were Detected in a Foetal Autopsy Study.

Authors:  Tulika Gupta; Kanchan Kapoor; A Sharma; A Huria
Journal:  J Clin Diagn Res       Date:  2012-12-15

10.  Correlation of ultrasound and renal scintigraphy in children with unilateral hydronephrosis in primary workup.

Authors:  E U Nitzsche; L B Zimmerhackl; R A Hawkins; B Stöver; A Frankenschmidt; G Sigmund; Y Choi; C K Hoh; E A Moser
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.